PATENT CLAIM ANALYSIS

Application Number: 16167567
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "404000"]

Abstract:
The present invention relates to the use of indolinones of general formula substituted in the 6 position, whereinR 1  to R 5  and X are defined as in claim  1 , the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases.

Claim (Index 1):
A method for treating fibrosis in rheumatoid arthritis, comprising administering to patient in need thereof a therapeutically effective amount of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone, or a salt thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.40476
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14982179', '13258714', '16083886', '15737125', '14718933']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7273520613927755
- 35 USC 102 Novelty (BERT): 0.5810831240909122
- Combined Prediction Score: 0.7127251676625892
- Mean Citation Score: 250.472216
- Max Citation Score: 460.8166
- Similarity Product: 438.4471632041574

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test